Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
: Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Grazia Franzosi M, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ, on behalf of the RE-LY investigators, Airaksinen J
: 2010
: Lancet
: 9745
: 376
: 9745
: 975
: 983
: 9
: 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(10)61194-4(external)